The AARS gene is associated with autosomal dominant Charcot-Marie-Tooth disease type 2N (CMT2N) (MedGen UID: 413754). The AARS gene also has preliminary evidence supporting a correlation with autosomal recessive early infantile epileptic encephalopathy 29 (EIEE29) (MedGen UID: 833802).
Order this gene as a single gene test.
Invitae tests that include this gene:
AARS is a rare cause of CMT, and the percentage of CMT attributed to pathogenic variants in AARS is unknown.
The gene AARS encodes the protein alanyl-tRNA synthetase. This highly conserved enzyme helps interpret the RNA code and transcribe proteins.
Invitae is a College of American Pathologists (CAP)-accredited and Clinical Laboratory Improvement Amendments (CLIA)-certified clinical diagnostic laboratory performing full-gene sequencing and deletion/duplication analysis using next-generation sequencing technology (NGS).
Our sequence analysis covers clinically important regions of each gene, including coding exons, +/- 10 base pairs of adjacent intronic sequence in the transcript listed below. In addition, analysis covers the select non-coding variants specifically defined in the table below. Any variants that fall outside these regions are not analyzed. Any specific limitations in the analysis of these genes are also listed in the table below.
Our analysis detects most intragenic deletions and duplications at single exon resolution. However, in rare situations, single-exon copy number events may not be analyzed due to inherent sequence properties or isolated reduction in data quality. If you are requesting the detection of a specific single-exon copy number variation, please contact Client Services before placing your order.
|Gene||Transcript reference||Sequencing analysis||Deletion/Duplication analysis|